» Articles » PMID: 36612003

Epigenetic Insights on PARP-1 Activity in Cancer Therapy

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2023 Jan 8
PMID 36612003
Authors
Affiliations
Soon will be listed here.
Abstract

The regulation of chromatin state and histone protein eviction have been proven essential during transcription and DNA repair. Poly(ADP-ribose) (PAR) polymerase 1 (PARP-1) and poly(ADP-ribosyl)ation (PARylation) are crucial mediators of these processes by affecting DNA/histone epigenetic events. DNA methylation/hydroxymethylation patterns and histone modifications are established by mutual coordination between all epigenetic modifiers. This review will focus on histones and DNA/histone epigenetic machinery that are direct targets of PARP-1 activity by covalent and non-covalent PARylation. The effects of these modifications on the activity/recruitment of epigenetic enzymes at DNA damage sites or gene regulatory regions will be outlined. Furthermore, based on the achievements made to the present, we will discuss the potential application of epigenetic-based therapy as a novel strategy for boosting the success of PARP inhibitors, improving cell sensitivity or overcoming drug resistance.

Citing Articles

Transcriptional regulation mechanism of PARP1 and its application in disease treatment.

Lu Y, Fu W, Xing W, Wu H, Zhang C, Xu D Epigenetics Chromatin. 2024; 17(1):26.

PMID: 39118189 PMC: 11308664. DOI: 10.1186/s13072-024-00550-w.


Apigenin protects against ischemic stroke by increasing DNA repair.

Ping N, Zuo K, Cai J, Rong C, Yu Z, Zhang X Front Pharmacol. 2024; 15:1362301.

PMID: 38746012 PMC: 11091408. DOI: 10.3389/fphar.2024.1362301.

References
1.
Nalabothula N, Al-jumaily T, Eteleeb A, Flight R, Xiaorong S, Moseley H . Genome-Wide Profiling of PARP1 Reveals an Interplay with Gene Regulatory Regions and DNA Methylation. PLoS One. 2015; 10(8):e0135410. PMC: 4549251. DOI: 10.1371/journal.pone.0135410. View

2.
Witcher M, Emerson B . Epigenetic silencing of the p16(INK4a) tumor suppressor is associated with loss of CTCF binding and a chromatin boundary. Mol Cell. 2009; 34(3):271-84. PMC: 2723750. DOI: 10.1016/j.molcel.2009.04.001. View

3.
Langelier M, Planck J, Roy S, Pascal J . Crystal structures of poly(ADP-ribose) polymerase-1 (PARP-1) zinc fingers bound to DNA: structural and functional insights into DNA-dependent PARP-1 activity. J Biol Chem. 2011; 286(12):10690-701. PMC: 3060520. DOI: 10.1074/jbc.M110.202507. View

4.
Jaspers J, Kersbergen A, Boon U, Sol W, Van Deemter L, Zander S . Loss of 53BP1 causes PARP inhibitor resistance in Brca1-mutated mouse mammary tumors. Cancer Discov. 2012; 3(1):68-81. PMC: 7518105. DOI: 10.1158/2159-8290.CD-12-0049. View

5.
Hassa P, Hottiger M . The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases. Front Biosci. 2007; 13:3046-82. DOI: 10.2741/2909. View